MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Uncover Sanfilippo syndrome's genetic roots. Genetic testing enables early diagnosis, personalized care, and access to trials, offering hope to affected families.
Explore how genetic testing plays a crucial role in diagnosing Seckel Syndrome, aiding early intervention, family planning, and guiding future therapeutic research.
Explore the impact of genetic testing in diagnosing Severe Early-Onset Axonal Neuropathy due to MFN2 deficiency, enhancing patient care, treatment, and family planning.
Explore the role of genetic testing in diagnosing Sialidosis Type 1, a rare neurodegenerative disorder, and how it aids in personalized treatment and family planning.
Genetic testing is vital for diagnosing Sotos syndrome, a rare disorder linked to NSD1 gene mutations, aiding early interventions and familial planning strategies.
Genetic testing unveils the mysteries of Spinocerebellar Ataxia (SCAN2), aiding early detection, personalized treatments, and informed family planning strategies.
Explore how genetic testing aids in diagnosing Stickler syndrome, predicts disease progression, and guides personalized treatment plans for improved patient outcomes.
Explore how genetic testing, specifically the HAVCR2Y82C mutation, revolutionizes the diagnosis and treatment of subcutaneous panniculitis-like T-cell lymphoma.